Cargando…
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth
BACKGROUND: There is growing evidence that emerging malignancies in solid tissues might be kept under control by physical intercellular contacts with normal fibroblasts. METHODS: Here we characterize transcriptional landscapes of fibroblasts that confronted cancer cells. We studied four pairs of in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472614/ https://www.ncbi.nlm.nih.gov/pubmed/26081588 http://dx.doi.org/10.1186/s13046-015-0178-x |
_version_ | 1782377076284719104 |
---|---|
author | Alexeyenko, Andrey Alkasalias, Twana Pavlova, Tatiana Szekely, Laszlo Kashuba, Vladimir Rundqvist, Helene Wiklund, Peter Egevad, Lars Csermely, Peter Korcsmaros, Tamas Guven, Hayrettin Klein, George |
author_facet | Alexeyenko, Andrey Alkasalias, Twana Pavlova, Tatiana Szekely, Laszlo Kashuba, Vladimir Rundqvist, Helene Wiklund, Peter Egevad, Lars Csermely, Peter Korcsmaros, Tamas Guven, Hayrettin Klein, George |
author_sort | Alexeyenko, Andrey |
collection | PubMed |
description | BACKGROUND: There is growing evidence that emerging malignancies in solid tissues might be kept under control by physical intercellular contacts with normal fibroblasts. METHODS: Here we characterize transcriptional landscapes of fibroblasts that confronted cancer cells. We studied four pairs of in vitro and ex vivo fibroblast lines which, within each pair, differed in their capacity to inhibit cancer cells. The natural process was modeled in vitro by confronting the fibroblasts with PC-3 cancer cells. Fibroblast transcriptomes were recorded by Affymetrix microarrays and then investigated using network analysis. RESULTS: The network enrichment analysis allowed us to separate confrontation- and inhibition-specific components of the fibroblast transcriptional response. Confrontation-specific differences were stronger and were characterized by changes in a number of pathways, including Rho, the YAP/TAZ cascade, NF-kB, and TGF-beta signaling, as well as the transcription factor RELA. Inhibition-specific differences were more subtle and characterized by involvement of Rho signaling at the pathway level and by potential individual regulators such as IL6, MAPK8, MAP2K4, PRKCA, JUN, STAT3, and STAT5A. CONCLUSIONS: We investigated the interaction between cancer cells and fibroblasts in order to shed light on the potential mechanisms and explain the differential inhibitory capacity of the latter, which enabled both a holistic view on the process and details at the gene/protein level. The combination of our methods pointed to proteins, such as members of the Rho pathway, pro-inflammatory signature and the YAP1/TAZ cascade, that warrant further investigation via tools of experimental perturbation. We also demonstrated functional congruence between the in vitro and ex vivo models. The microarray data are made available via the Gene Expression Omnibus as GSE57199. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-015-0178-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4472614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44726142015-06-20 Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth Alexeyenko, Andrey Alkasalias, Twana Pavlova, Tatiana Szekely, Laszlo Kashuba, Vladimir Rundqvist, Helene Wiklund, Peter Egevad, Lars Csermely, Peter Korcsmaros, Tamas Guven, Hayrettin Klein, George J Exp Clin Cancer Res Research Article BACKGROUND: There is growing evidence that emerging malignancies in solid tissues might be kept under control by physical intercellular contacts with normal fibroblasts. METHODS: Here we characterize transcriptional landscapes of fibroblasts that confronted cancer cells. We studied four pairs of in vitro and ex vivo fibroblast lines which, within each pair, differed in their capacity to inhibit cancer cells. The natural process was modeled in vitro by confronting the fibroblasts with PC-3 cancer cells. Fibroblast transcriptomes were recorded by Affymetrix microarrays and then investigated using network analysis. RESULTS: The network enrichment analysis allowed us to separate confrontation- and inhibition-specific components of the fibroblast transcriptional response. Confrontation-specific differences were stronger and were characterized by changes in a number of pathways, including Rho, the YAP/TAZ cascade, NF-kB, and TGF-beta signaling, as well as the transcription factor RELA. Inhibition-specific differences were more subtle and characterized by involvement of Rho signaling at the pathway level and by potential individual regulators such as IL6, MAPK8, MAP2K4, PRKCA, JUN, STAT3, and STAT5A. CONCLUSIONS: We investigated the interaction between cancer cells and fibroblasts in order to shed light on the potential mechanisms and explain the differential inhibitory capacity of the latter, which enabled both a holistic view on the process and details at the gene/protein level. The combination of our methods pointed to proteins, such as members of the Rho pathway, pro-inflammatory signature and the YAP1/TAZ cascade, that warrant further investigation via tools of experimental perturbation. We also demonstrated functional congruence between the in vitro and ex vivo models. The microarray data are made available via the Gene Expression Omnibus as GSE57199. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-015-0178-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-18 /pmc/articles/PMC4472614/ /pubmed/26081588 http://dx.doi.org/10.1186/s13046-015-0178-x Text en © Alexeyenko et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Alexeyenko, Andrey Alkasalias, Twana Pavlova, Tatiana Szekely, Laszlo Kashuba, Vladimir Rundqvist, Helene Wiklund, Peter Egevad, Lars Csermely, Peter Korcsmaros, Tamas Guven, Hayrettin Klein, George Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title | Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title_full | Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title_fullStr | Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title_full_unstemmed | Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title_short | Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
title_sort | confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472614/ https://www.ncbi.nlm.nih.gov/pubmed/26081588 http://dx.doi.org/10.1186/s13046-015-0178-x |
work_keys_str_mv | AT alexeyenkoandrey confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT alkasaliastwana confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT pavlovatatiana confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT szekelylaszlo confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT kashubavladimir confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT rundqvisthelene confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT wiklundpeter confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT egevadlars confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT csermelypeter confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT korcsmarostamas confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT guvenhayrettin confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth AT kleingeorge confrontationoffibroblastswithcancercellsinvitrogenenetworkanalysisoftranscriptomechangesanddifferentialcapacitytoinhibittumorgrowth |